EBD Group is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BioPharm America 2014 EBD Group MassBio
Share/Follow Us
Share this:
Follow this event:

BioPharm America™ Press Releases

News for BioPharm America™ 2016 will be available soon.

September 24, 2015BioPharm America™ 2015 convenes over 800 global life science investors, leaders in Boston The eighth edition of BioPharm America 2015 life science partnering event wrapped up last week in Boston with overwhelming success. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the event brought together cutting edge biotech companies and early stage startups, with executives from global pharmaceutical companies, finance, invest...  more ►

September 16, 2015Best of Boston biotech startups win recognition at BioPharm America™ 2015 during Johnson & Johnson Innovation Startup Day competition EBD Group today announced the winners of the first annual Johnson & Johnson Innovation Biotech Startup Day competition at the eighth annual BioPharm America 2015 life science partnering event in Boston. The winner of the Johnson & Johnson Innovation Startup Day competition grand prize went to Proteorex Therapeutics Inc. for their innovative technology and services t...  more ►

September 2, 2015EBD Group to announce the Johnson & Johnson Innovation Startup Day competition grand prize winner at BioPharm America™ 2015 Partnering EventLeaders in life sciences to gather in Boston September 15–17 for partnering event
September 2, 2015: BioPharm America 2015 life science partnering event will take place in Boston September 15–17 at the Boston Marriott Copley Place. The event will convene members of the global life science community to forge connections among startups, entrepreneurs and the drug development industry. A pitch contest for startup and young companies will take place in ...  more ►

July 22, 2015BioPharm America™ 2015 to bring industry heavy hitters and biotech disruptors to Boston September 15–17 BioPharm America 2015 will once again bring the most talented, innovative leaders of biotech and pharma to Boston this September 15–17 at the Boston Marriott Copley Place. An increasing number of industry heavy hitters have successfully led and exited large corporations and are now investing their experience, clout and personal finances to reseed the life science ecosy...  more ►

June 9, 2015Spotlight on Boston Business Facts The life sciences corridor in Massachusetts combines the cities of Somerville, Cambridge, Boston, Quincy and Braintree, and is home to over 450 companies within the life science industry cluster. There were USD 1,802 billion of venture investments in Massachusetts biotechs in 2014. Massachusetts has seen 30 companies go public in the last two years. Some of the largest bio...  more ►

May 20, 2015Engage and De-Risk: BioPharm America™ 2015 draws life science dealmaking ecosystem to Boston this September 15–17 EBD Group and MassBio present the eighth annual BioPharm America international life science partnering conference September 15–17 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings executives from the life science ecosystem together to de-risk the environment inherent to biotech and engage in disruptive dealmaking. BioPharm Am...  more ►


partnering360® Blog

May 19, 2016 How drug development is like your diet If you’re like me, you read the dailies. Companies run the gamut from riding high and plump on investment infusion to rock hard abs times when they’re all muscle and no fat, and, possibly back again. With summer coming, it occurred to me that drug development cycles are very much like dieting,... more ►

May 12, 2016 From Zika virus to fast, high quality clinical trials: Puerto Rico’s Consortium for Clinical Investigation (PRCCI) Situated just 1,200 miles from the mainland US, a hotspot of clinical trial activity is being established on a small island paradise. If you haven’t heard of the Puerto Rico Consortium for Clinical Investigation (PRCCI), you should. What this organization is doing in clinical research trials for... more ►

April 29, 2016 Digital Health: Still a brave new world At this year’s BIO-Europe Spring® panel on “The Convergence of Therapeutics and Digital Health,” two panelists from big pharma joined two from Scandinavian digital health companies, agreeing that while the platform for digital health technologies is strong in Europe, much... more ►

April 19, 2016 The characteristics of a “winning” biotech startup QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious diseases, won the Start-up Slam: Sweden biotech competition at BIO-Europe Spring® 2016 in Stockholm, Sweden earlier this month. QureTech Bio AB participated in the pitching competition sponsored by... more ►

April 5, 2016 Images of BIO-Europe Spring® 2016 in Stockholm [See image gallery at www.partnering360.com] more ►



partnering360:Insight Latest headlines from partnering360:Insight

May 18, 2016 Italy’s A. Menarini IFR aims to expand into the US and Japan Giammario Piras, corporate licensing director at A. Menarini IFR, explains why and how Italy's largest drug maker plans to expand into the US and Japanese markets. more ►

May 18, 2016 BeyondSpring Pharmaceuticals outlines Plinabulin plans, wants marketing partner BeyondSpring Pharmaceuticals' chief medical officer Ramon Mohanial outlines plans for advancing the group's immuno-oncology pipeline, with ongoing Phase II and III trials of its most promising assets. more ►

May 17, 2016 Accellta CEO says israeli stem cell specialist seeks global partners Itzchak Angel, CEO of Israeli stem cell specialist Accellta, discusses the group's stem cell culturing process and future expansion plans including a planned USD 15 million capital raising exercise and ongoing search for corporate partners. more ►

May 17, 2016 AngioDesign tailoring next-generation ACE inhibitors Mario Ehlers, Chairman of drug discovery group Angio-Design (UK) explains why the design of specific domain-selective ACE inhibitors is expected to produce next-generation drugs that are safer and more effective—and generate blockbuster returns. more ►

May 17, 2016 4SC AG’s CSO outlines epigenetics strategy 4SC AG Chief Science Officer says the German cancer drug developer is conducting a Phase II trial of lead candidate ACE inhibitor resminostat in cutaneous T-cell lymphoma. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use